Lead Product(s): Undisclosed
Therapeutic Area: Oncology
Highest Development Status: Discovery Product Type: Undisclosed
Partner/Sponsor/Collaborator: University of Montreal
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement May 04, 2020
University of Montreal/IRICoR will conduct and finance the research program until the license is exercised. Ipsen would assume all development activities and commercialize the drug candidate globally.